Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.
Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review.
Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware.
RNA Cytosine Methyltransferases NSUN1 and NSUN2 Mediate the Lineage-Associated Resistance to Venetoclax in Leukemia
Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress.
Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress. Arch Med Res. 2012 Nov; 43(8):694-8.
View in:
PubMed
subject areas
Alzheimer Disease
Amyloidosis
Antibodies, Monoclonal, Humanized
Energy Metabolism
Humans
Mitochondria
Models, Neurological
Oxidative Stress
Phosphorylation
Systems Biology
tau Proteins
Treatment Failure
authors with profiles
George Perry